Similar companies
Did Terns Pharmaceuticals Beat Earnings?
Terns Pharmaceuticals (TERN) reported Q3 '25 revenue of $0.
AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Terns Pharmaceuticals’s job postings, web traffic, and employee business outlook. See the full TERN stock analysis or the earnings calendar for upcoming reports.
Terns Pharmaceuticals Quarterly Financial Trends
| Metric | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.3M | — | — | — | — | — | — | — |
| Gross margin | 83.4% | — | — | — | — | — | — | — |
| Operating margin | -1,819.8% | — | — | — | — | — | — | — |
| Net income | -21M | -22M | -23M | -22M | -22M | -24M | -24M | -25M |
| Net margin | -1,589.9% | — | — | — | — | — | — | — |
| EPS | — | — | — | — | — | — | — | — |
Terns Pharmaceuticals Earnings Trend Analysis
Over the eight quarters from Q4 '23 to Q3 '25, Terns Pharmaceuticals’s quarterly revenue moved from $1.3M to $0.
When Is Terns Pharmaceuticals’s Next Earnings Date?
Terns Pharmaceuticals reports earnings on a quarterly schedule. Its most recent report covered Q3 '25. For the confirmed upcoming date — and every other company reporting soon — see the TERN earnings calendar.
Frequently Asked Questions: Terns Pharmaceuticals Earnings
Terns Pharmaceuticals's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.
Terns Pharmaceuticals reported Q3 '25 revenue of $0.
Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the TERN AI Score.
